Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705038200 on August 8, 2007

J. Biol. Chem., Vol. 282, Issue 40, 29264-29272, October 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/40/29264    most recent
M705038200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsukumo, Y.
Right arrow Articles by Tsuruo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsukumo, Y.
Right arrow Articles by Tsuruo, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nucleobindin 1 Controls the Unfolded Protein Response by Inhibiting ATF6 Activation*Formula

Yoshinori Tsukumo{ddagger}§, Akihiro Tomida{ddagger}§1, Osamu Kitahara2, Yusuke Nakamura, Shinichi Asada||, Kazutoshi Mori||, and Takashi Tsuruo{ddagger}§

From the {ddagger}Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan, the §Laboratory of Cell Growth and Regulation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan, the Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, the ||Graduate School of Biostudies, Kyoto University, Kyoto 606-8304 Japan

In response to endoplasmic reticulum (ER) stress, activating transcription factor 6 (ATF6), an ER membrane-anchored transcription factor, is transported to the Golgi apparatus and cleaved by site-1 protease (S1P) to activate the unfolded protein response (UPR). Here, we identified nucleobindin 1 (NUCB1) as a novel repressor of the S1P-mediated ATF6 activation. NUCB1 is an ER stress-inducible gene with the promoter region having functional cis-elements for transcriptional activation by ATF6. Overexpression of NUCB1 inhibits S1P-mediated ATF6 cleavage without affecting ER-to-Golgi transport of ATF6, whereas knock-down of NUCB1 by siRNA accelerates ATF6 cleavage during ER stress. NUCB1 protein localizes in the Golgi apparatus, and disruption of the Golgi localization results in loss of the ATF6-inhibitiory activity. Consistent with these observations, NUCB1 can suppress physical interaction of S1P-ATF6 during ER stress. Together, our results demonstrate that NUCB1 is the first-identified, Golgi-localized negative feedback regulator in the ATF6-mediated branch of the UPR.


Received for publication, June 19, 2007 , and in revised form, August 6, 2007.

* This work was supported in part by a grant-in-aid for scientific research on priority areas for cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. T.) and the Grant-in-Aid for Cancer Research (15-2) from the Ministry of Health, Labour and Welfare and NOVARTIS Foundation (Japan) for the Promotion (to A. T.) and aid from Ishizu Scholarship Foundation (to Y. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S5.

2 Present address: Pharmacology Research Laboratories II, Pharmaceutical Research Division. Takeda Pharmaceutical Company Limited 10, Wadai, Tsukuba, Ibaraki, 300-4293, Japan.

1 To whom correspondence should be addressed. Tel.: 81-3-3520-0111(ext. 5405); Fax: 81-3-3570-0484; E-mail: akihiro.tomida{at}jfcr.or.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Saito, A. Furuno, J. Sakurai, A. Sakamoto, H.-R. Park, K. Shin-ya, T. Tsuruo, and A. Tomida
Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
Cancer Res., May 15, 2009; 69(10): 4225 - 4234.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Gkogkas, S. Middleton, A. M. Kremer, C. Wardrope, M. Hannah, T. H. Gillingwater, and P. Skehel
VAPB interacts with and modulates the activity of ATF6
Hum. Mol. Genet., June 1, 2008; 17(11): 1517 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. C. Glembotski
Endoplasmic Reticulum Stress in the Heart
Circ. Res., November 9, 2007; 101(10): 975 - 984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement